An innovative, promising topical treatment for psoriasis: a Romanian clinical study.

An innovative, promising topical treatment for psoriasis: a Romanian clinical study. J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2 Suppl 3):109-13 Authors: Gianfaldoni S, Hercogovấ J, Fioranelli M, Chokoeva AA, Tchernev G, Wollina U, Tirant M, Novotny F, Roccia MG, Maximov GK, França K, Lotti T Abstract Psoriasis is a chronic inflammatory disease with negative impacts both physically and psychologically. It is a common disorder affecting 2-3% of the total world population, in some cases causing changes to the nail and joints as well as skin lesions. The cutaneous manifestations of psoriasis can vary in morphology and severity and therapy should be tailored accordingly. Even if today many therapeutic options are available for psoriasis treatment, none of them provide excellent clinical results without the risk of side effects. The authors investigate the efficacy of Dr. Michaels® (Soratinex®) natural products in the topical treatments of a group of psoriatic patients. Sixty-two patients (34 male/28 female) from Romania, aged 18-70 years (mean age: 52 years), affected by a mild to severe form of chronic plaque psoriasis were included in this study. Each patient has been treated with a triphasic application of Dr. Michaels® (Soratinex®) natural products, twice a day for six weeks. The products were applied on skin and scalp lesions, but not on the face, genital and flexures. The evaluation of the tested products was based on the...
Source: Journal of Biological Regulators and Homeostatic Agents - Category: Biomedical Science Tags: J Biol Regul Homeost Agents Source Type: research